Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.addr.2014.10.020PMID 25453266PMCID PMC4465296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer

  2014cited by this paper
• MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.

  2014cited by this paper
• Smoking and microRNA dysregulation: a cancerous combination.

  2014cited by this paper
• MicroRNA modulation combined with sunitinib as a novel therapeutic strategy for pancreatic cancer

  2014cited by this paper
• A microRNA meta-signature for pancreatic ductal adenocarcinoma

  2014cited by this paper
• MicroRNAs as novel biomarkers for pancreatic cancer diagnosis: a meta-analysis based on 18 articles

  2014cited by this paper
• Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy

  2014cited by this paper
• MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer

  2014cited by this paper
• Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.

  2014cited by this paper
• A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression

  2014cited by this paper
• Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.

  2014cited by this paper
• MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer

  2014cited by this paper
• Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.

  2014cited by this paper
• Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs

  2013cited by this paper
• Roles for KRAS in pancreatic tumor development and progression.

  2013cited by this paper
• MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

  2013cited by this paper
• Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine

  2013cited by this paper
• De-Regulated MicroRNAs in Pediatric Cancer Stem Cells Target Pathways Involved in Cell Proliferation, Cell Cycle and Development

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• Mutant p53 drives invasion in breast tumors through up-regulation of miR-155

  2013cited by this paper
• Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

  2013cited by this paper
• p53 mutations in cancer

  2013cited by this paper
• Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties.

  2013cited by this paper
• The Cyclin-dependent Kinase Inhibitor p16INK4a Physically Interacts with Transcription Factor Sp1 and Cyclin-dependent Kinase 4 to Transactivate MicroRNA-141 and MicroRNA-146b-5p Spontaneously and in Response to Ultraviolet Light-induced DNA Damage*

  2013cited by this paper
• MicroRNA-221 Mediates the Effects of PDGF-BB on Migration, Proliferation, and the Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells

  2013cited by this paper
• MicroRNA-gene signaling pathways in pancreatic cancer.

  2013cited by this paper
• Treatment of HCV infection by targeting microRNA.

  2013cited by this paper
• Combined Serum CA19-9 and miR-27a-3p in Peripheral Blood Mononuclear Cells to Diagnose Pancreatic Cancer

  2013cited by this paper
• The Oncogenic Role of microRNA-130a/301a/454 in Human Colorectal Cancer via Targeting Smad4 Expression

  2013cited by this paper
• Targeting miR-21 for the therapy of pancreatic cancer.

  2013cited by this paper
• Prospects of miRNA-based therapy for pancreatic cancer.

  2013cited by this paper
• Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.

  2013cited by this paper
• A molecular-beacon-based screen for small molecule inhibitors of miRNA maturation.

  2013cited by this paper
• The proto-oncogene KRAS is targeted by miR-200c

  2013cited by this paper
• Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance

  2013cited by this paper
• Targeting microRNAs in pancreatic cancer: microplayers in the big game.

  2013cited by this paper
• MUC1 Regulates Expression of Multiple microRNAs Involved in Pancreatic Tumor Progression, Including the miR-200c/141 Cluster

  2013cited by this paper
• MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls

  2013cited by this paper
• The p53/microRNA network in cancer: experimental and bioinformatics approaches.

  2013cited by this paper
• MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer

  2013cited by this paper
• Fluorescence In Situ Hybridization for MicroRNA Detection in Archived Oral Cancer Tissues

  2012cited by this paper
• Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer

  2012cited by this paper
• Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.

  2012cited by this paper
• The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer

  2012cited by this paper
• Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.

  2012cited by this paper
• Inhibition of miR-15 Protects Against Cardiac Ischemic Injury

  2012cited by this paper
• Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family

  2012cited by this paper
• Clinical outcome prediction by microRNAs in human cancer: a systematic review.

  2012cited by this paper
• miR-34 – a microRNA replacement therapy is headed to the clinic

  2012cited by this paper
• The emerging functions of the p53-miRNA network in stem cell biology

  2012cited by this paper
• Prognostic MicroRNAs in Cancer Tissue from Patients Operated for Pancreatic Cancer—Five MicroRNAs in a Prognostic Index

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• MicroRNA profiling: approaches and considerations

  2012cited by this paper
• Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway

  2012cited by this paper
• Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis

  2012cited by this paper
• Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.

  2012cited by this paper
• Molecular Pathways Molecular Pathways : Targeting the TGF-b Pathway for Cancer Therapy

  2012cited by this paper
• Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition

  2012cited by this paper
• MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog*

  2012cited by this paper
• Diagnostic value of microRNA for pancreatic cancer: a meta-analysis

  2012cited by this paper
• MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene

  2012cited by this paper
• Mutant p53: one name, many proteins.

  2012cited by this paper
• MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway

  2012cited by this paper
• Global microRNA expression profiling of microdissected tissues identifies miR‐135b as a novel biomarker for pancreatic ductal adenocarcinoma

  2012cited by this paper
• MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors

  2012cited by this paper
• [Expression of miR-216a in pancreatic cancer and its clinical significance].

  2012cited by this paper
• Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas

  2012cited by this paper
• MicroRNA miR-548d Is a Superior Regulator in Pancreatic Cancer

  2012cited by this paper
• Recent progress in microRNA study: Benefits from technique advance

  2012cited by this paper
• MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

  2012cited by this paper
• Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation

  2012cited by this paper
• MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer

  2012cited by this paper
• miR‐301a promotes pancreatic cancer cell proliferation by directly inhibiting bim expression

  2012cited by this paper
• MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

  2012cited by this paper
• Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue

  2012cited by this paper
• Smad‐mediated regulation of microRNA biosynthesis

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer

  2012cited by this paper
• Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer

  2012cited by this paper
• miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma

  2011cited by this paper
• miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

  2011cited by this paper
• CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.

  2011cited by this paper
• Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells

  2011cited by this paper
• A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival

  2011cited by this paper
• The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells

  2011cited by this paper
• MicroRNA 483‐3p suppresses the expression of DPC4/Smad4 in pancreatic cancer

  2011cited by this paper
• Cyclin-dependent kinase 1 expression is inhibited by p16INK4a at the post-transcriptional level through the microRNA pathway

  2011cited by this paper
• MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B

  2011cited by this paper
• Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

  2011cited by this paper
• Gli proteins in development and disease.

  2011cited by this paper
• microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C

  2011cited by this paper
• miR‐301a as an NF‐κB activator in pancreatic cancer cells

  2011cited by this paper
• Major Molecular Markers in Pancreatic Ductal Adenocarcinoma and Their Roles in Screening, Diagnosis, Prognosis, and Treatment

  2011cited by this paper
• MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer.

  2011cited by this paper
• Human glioma growth is controlled by microRNA-10b.

  2011cited by this paper
• Use of target protector morpholinos to analyze the physiological roles of specific miRNA-mRNA pairs in vivo

  2011cited by this paper
• Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

  2011cited by this paper
• Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells.

  2011cited by this paper
• MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis.

  2011cited by this paper
• MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

  2011cited by this paper

• microRNAs in pancreatic cancer: Key modulators of tumor progression and therapeutic resistance.

  2026cites this paper
• Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer.

  2025cites this paper
• Extracellular derived-exosomal micrornas in pancreatic cancer: investigating their diagnostic importance and potential targets for the prevention and treatment in pancreatic cancer

  2025cites this paper
• Extracellular Vesicle-Associated MicroRNA-25-3p Derived from Pancreatic Cancer Cells Promotes Hepatic Stellate Cell Activation and Enhances Cancer Progression.

  2025cites this paper
• Flavonoids as modulators of miRNA expression in pancreatic cancer: Pathways, Mechanisms, And Therapeutic Potential.

  2024cites this paper
• Potential of sonobiopsy as a novel diagnosis tool for brain cancer

  2024cites this paper
• Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review

  2024cites this paper
• Epigenetic Regulation of Autophagy in Bone Metabolism

  2024cites this paper
• An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation.

  2024cites this paper
• Dysregulated miRNAs modulate tumor microenvironment associated signaling networks in pancreatic ductal adenocarcinoma

  2023cites this paper
• KRAS Hijacks the miRNA Regulatory Pathway in Cancer

  2023cites this paper
• Trigging stepwise-strand displacement amplification lights up numerous G-quadruplex for colorimetric signaling of serum microRNAs

  2023cites this paper
• Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study

  2023cites this paper
• Current understanding and future prospects on Berberine for anticancer therapy

  2023cites this paper
• MicroRNA electrochemical biosensors forpancreatic cancer.

  2023cites this paper
• Association between microRNAs and chemoresistance in pancreatic cancer: Current knowledge, new insights, and forthcoming perspectives.

  2022cites this paper
• Investigating the interference of Single Nucleotide Polymorphisms with miRNA mediated gene regulation in pancreatic ductal adenocarcinoma: an in silico approach.

  2022cites this paper
• MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

  2022cites this paper
• DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis.

  2022cites this paper
• Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

  2021cites this paper
• The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review

  2021cites this paper
• MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer

  2021cites this paper
• Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.

  2021cites this paper
• MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2

  2021cites this paper
• The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma

  2021cites this paper
• YOD1 serves as a potential prognostic biomarker for pancreatic cancer

  2021cites this paper
• The Role of microRNA in Pancreatic Cancer

  2021cites this paper
• The Anti-Cancer Mechanisms of Berberine: A Review

  2020cites this paper
• Role of miRNA clusters in epithelial to mesenchymal transition in cancer.

  2020influential citation
• A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis

  2020cites this paper
• Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Screening potential microRNAs associated with pancreatic cancer: Data mining based on RNA sequencing and microarrays

  2020cites this paper
• Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.

  2019cites this paper
• MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential

  2019cites this paper
• Long noncoding RNA AK089579 inhibits epithelial‐to‐mesenchymal transition of peritoneal mesothelial cells by competitively binding to microRNA‐296‐3p via DOK2 in peritoneal fibrosis

  2019cites this paper
• Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis

  2019cites this paper
• Hexokinase 2 dimerization and interaction with voltage‐dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer

  2019cites this paper
• Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy.

  2019cites this paper
• circ-LDLRAD3 regulates cell proliferation, migration and invasion of pancreatic cancer by miR-876-3p/STAT3

  2019cites this paper
• The targeting of non-coding RNAs by curcumin: Facts and hopes for cancer therapy

  2019cites this paper
• Triple-Helix Molecular Switch Electrochemiluminescence Nano-amplifier based on a S-doped Lu2O3/Ag2S Pair for Sensitive MicroRNA Detection.

  2019cites this paper
• Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists

  2018cites this paper
• Delivery of MicroRNA with CXCR4-Targeted Nanoparticles in Metastatic Cancer Treatment

  2018cites this paper
• Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.

  2018cites this paper
• Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.

  2018cites this paper
• Biological Entanglement–Like Effect After Communication of Fish Prior to X-Ray Exposure

  2018cites this paper
• miR-128 induces pancreas cancer cell apoptosis by targeting MDM4.

  2018cites this paper
• Challenges in diagnosis of pancreatic cancer

  2018cites this paper
• A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma

  2018cites this paper
• Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

  2018cites this paper
• Dinitrosopiperazine‐decreased PKP3 through upregulating miR‐149 participates in nasopharyngeal carcinoma metastasis

  2018cites this paper
• Ultrasensitive electrochemical detection of miRNA based on DNA strand displacement polymerization and Ca2+-dependent DNAzyme cleavage.

  2018cites this paper
• Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cells.

  2017cites this paper
• MicroRNA‐128 promotes apoptosis in lung cancer by directly targeting NIMA‐related kinase 2

  2017cites this paper
• MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells

  2017cites this paper
• Gankyrin as a potential therapeutic target for cancer

  2017cites this paper
• Nanoplasmonic sensors for detecting circulating cancer biomarkers☆

  2017cites this paper
• Ultrasensitive MicroRNA Assay via Surface Plasmon Resonance Responses of Au@Ag Nanorods Etching.

  2017cites this paper
• Differential expression of microRNA let-7b-5p regulates burn-induced hyperglycemia

  2017cites this paper
• MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.

  2017cites this paper
• miR-493 inhibits proliferation and invasion in pancreatic cancer cells and inversely regulated hERG1 expression

  2017cites this paper
• Chronic Pancreatitis

  2017cites this paper
• Investigation into mechanisms of metastasis in breast cancer and pancreatic cancer

  2017cites this paper
• The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer

  2017cites this paper
• Effects of RNAi-mediated MUC4 gene silencing on the proliferation and migration of human pancreatic carcinoma BxPC-3 cells.

  2016cites this paper
• Prognostic Impact of Cancer Stem Cell-Like Phenotypes in Pancreatic Ductal Adenocarcinoma

  2016cites this paper
• Biomarkers and Targeted Therapy in Pancreatic Cancer

  2016cites this paper
• MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1

  2016cites this paper
• The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma

  2016cites this paper
• Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity

  2016cites this paper
• The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma

  2016cites this paper
• High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer

  2016cites this paper
• MicroRNA-1291 targets the FOXA2-AGR2 pathway to suppress pancreatic cancer cell proliferation and tumorigenesis

  2016cites this paper
• Advance in microRNA as a potential biomarker for early detection of pancreatic cancer

  2016influential citation
• Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma

  2016cites this paper
• Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study

  2016cites this paper
• Poly r(C) binding protein is post-transcriptionally repressed by MiR-490-3p to potentiate squamous cell carcinoma

  2016cites this paper
• Circulating microRNAs as Potential Diagnostic, Prognostic and Therapeutic Targets in Pancreatic Cancer.

  2016cites this paper
• Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers

  2016cites this paper
• Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer

  2016cites this paper
• Pancreatic cancer stem cell markers and exosomes - the incentive push.

  2016cites this paper
• Significance of microRNA-based biomarkers for pancreatic cancer.

  2015cites this paper
• Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer

  2015cites this paper
• Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication.

  2015cites this paper
• microRNAs in the Malignant Transformation Process.

  2015cites this paper
• Long noncoding RNAs and hepatocellular carcinoma.

  2015cites this paper
• Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.

  2015cites this paper
• Evaluation of a metalloporphyrin (THPPMnCl) for necrosis-affinity in rat models of necrosis

  2015cites this paper
• Circulating microRNAs as diagnostic biomarkers for pancreatic cancer

  2015cites this paper
• Circulating RNAs as new biomarkers for detecting pancreatic cancer.

  2015cites this paper
• Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model

  2015cites this paper
• Chronic Pancreatitis and Pancreatic Cancer

  2014cites this paper